Determinants of Quality of Life in a Psoriasis Population in Northern Sweden

Acta Dermato-Venereologica

Volumn 84, Issue 1, 2004, Pages 37-43

  Uttjek, Margaretha ^a   Dufåker, Mona ^a   Nygren, Lennart ^a   Stenberg, Berndt ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Age; Cost; Distance; Extension; Gender; Joint symptoms

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTHROPATHY; ARTICLE; CHILD; EMPLOYMENT; FEMALE; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HUMAN; INCOME; INFANT; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OCCUPATION; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; SOCIOECONOMICS; SWEDEN;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; SWEDEN;

EID: 10744226159     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550310015833     Document Type: Article

References (28)

1. Rapp SR, Feldman SR, Fleischer Jr AB, Reboussin DM, Lexum ML. Health-related quality of life in psoriasis. A biopsychosocial model and measures. In: Rajagopalan R, Sherertz EF, Anderson RT, eds. Care management of skin diseases. Life quality and economic impact. New York, NY: Marcel Dekker Inc. 1998: 125-145.
2. Gupta MA, Gupta AK. The psoriasis life stress inventory. A preliminary index of psoriasis-related stress. Acta Derm Venereol 1995; 75: 240-243.
3. Finlay AY. Quality-of-life issues and economic burden of psoriasis and atopic dermatitis. Rationale for treatment. Clin Drug Invest 1995; 10: 1-6.
4. Ramsay B, O'Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988; 118: 195-201.
5. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989; 146: 53-63.
6. Doward LC, McKenna SP. Evolution of quality-of-life assessment. In: Rajagopalan R, Scherertz EF, Anderson RT, eds. Care management of skin diseases, life quality and economic impact. New York, NY: Marcel Dekker Inc. 1998: 9-33.
7. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997; 136: 305-314.
8. Finlay AY, Khan GK. Dermatology life quality index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
9. Maslow AH. Motivation and personality, 3rd edn. New York, NY: Addison Wesley Longman Inc. 1970: 15-45.
10. Joyce CRB, McGee HM, O'Boyle CA. Individual quality of life: approaches to conceptualisation and assessment. Singapore: Harwood Academic Publishers, 1999: 3-7.
11. Lundberg L, Johannesson M, Silverdahl M, et al. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 2000; 80: 430-434.
12. Hellgren L. Psoriasis. The prevalence in sex, age and occupational groups in total populations in Sweden. Morphology, inheritance and association with other skin and rheumatic diseases. Uppsala, Sweden: Almqvist & Wiksells Boktryckeri AB, 1967.
13. Fredriksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
14. Fleischer Jr AB, Feldman SR, Dekle CL. The SAPASI is valid and responsive to psoriasis disease severity changes in a multi-center clinical trial. J Dermatol 1999; 26: 210-215.
15. Zachariae R, Zacharie C, Ibsen H, Mortensen TJ, Wulf HC. Dermatology Life Quality Index: data from Danish inpatients and outpatients. Acta Derm Venereol 2000; 80: 272-276.
16. Touw CR, Hakkaart-van Roijen L, Verbom P, Paul C, Rutten FFH, Finlay AY. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol 2001; 144: 967-972.
17. Alenius G-M, Stenberg B, Stenlund H, Lundblad M, Dahlqvist Rantapää S. Inflammatory joint manifestations are prevalent in psoriasis: a prevalence study of joint and axial involvement in psoriatic patients and an evaluation of a psoriatic and arthritic questionnaire. J Rheumatol 2002; 29: 2577-2582.
18. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132: 236-244.
19. Gupta MA, Gupta AK, Ellis CN, Voorhees JJ. Some psychosomatic aspects of psoriasis. Adv Dermatol 1990; 5: 21-30.
20. Moberg E. Objective methods for determining the functional value of sensibility in the hand. J Bone Joint Surg 1958; 40B: 454-476.
21. Synnott A. The body social. Symbolism, self and society. London: Routledge, 1993: 1-2, 156-158, 167-168.
22. Featherstone M. Consumer culture and postmodernism. Bristol: J. W. Arrowsmith Ltd. 1991: 83-94.
23. Swanbeck G, Inerot A, Martinsson T, Wahlström J, Enerbäck C, Enlund F, et al. Age at onset and different types of psoriasis. Br J Dermatol 1995; 133: 768-773.
24. Wahl A, Hanestad BR, Wiklund I, Moum T. Coping and quality of life in patients with psoriasis. Qual Life Res 1999; 8: 427-433.
25. Strauss AL, Glaser BG. Chronic illness and the quality of life. St Louis: C. V. Mosby Company, 1975: 54-65.
26. Shilling C. The body and social theory. London: Sage Publications, 1993: 31-34.
27. Roenigk RK, Roenigk HH. Sex differences in the psychological effects of psoriasis. Cutis 1978; 21: 529-533.
28. Bihagen E, Halleröd B. The crucial aspect of class: an empirical assessment of the relevance of class analysis with Swedish data covering the late twentieth century. Work, Employment & Society 2000; 14: 307-330.